🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective is the observation and description of the preliminary...
Status
Terminated
Location
Hauttumorcentrum Charité (HTCC)
Start Date
2013-02
Trial ID
NCT01808950
Treatments Being Tested
The study is designed to see if a course of injections containing the NY-ES...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2009-02
Trial ID
NCT00821652
The application of the TLR7/8 (Toll Like Receptor) agonist gel (immune resp...
Status
Completed
Location
University of British Columbia Vancouver General Hospital
Start Date
2013-04
Trial ID
NCT01737580
Treatments Being Tested
The primary purpose of this study is to evaluate the effectiveness in adult...
Status
Completed
Location
Oregon Medical Research Center
Start Date
2004-08
Trial ID
NCT00117923
Treatments Being Tested
The primary purpose of this study is to evaluate the effectiveness in pedia...
Status
Completed
Location
Arkansas
Start Date
2005-03
Trial ID
NCT00116662
Treatments Being Tested
A Dose-Finding Study of Resiquimod Evaluating Safety and Efficacy in Patien...
Status
Completed
Location
Hauttumorcentrum Charité (HTCC)
Start Date
2012-05
Trial ID
NCT01583816
Treatments Being Tested
The main purpose of this study is to examine the safety and tolerability of...
Status
Completed
Location
Yale Comprehensive Cancer Center
Start Date
2009-09
Trial ID
NCT00948961
Treatments Being Tested
The primary purpose of this study is to evaluate the effectiveness in pedia...
Status
Completed
Location
Children's Clinic of Jonesboro, PA
Start Date
2005-03
Trial ID
NCT00116675
Treatments Being Tested
The primary purpose of this study is to evaluate the effectiveness in adult...
Status
Completed
Location
Minnesota Clinical Study Center
Start Date
2004-10
Trial ID
NCT00117871
Treatments Being Tested
Determine the recurrence rate of actinic keratosis (AK) lesions in patients...
Status
Terminated
Location
Hauttumorcentrum Charité (HTCC)
Start Date
2013-01
Trial ID
NCT01806961